Apimeds Pharmaceuticals US (APUS) Convertible Debt (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) recorded Convertible Debt of $386,676 in Q3 2025, unchanged from the prior quarter.
Powered by 
Analysis
Apimeds Pharmaceuticals US (APUS) Convertible Debt (2024 - 2025) Analysis & Trends
At the end of FY2024, Apimeds Pharmaceuticals US reported Convertible Debt of $346,844.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Apimeds Pharmaceuticals US | 5.65 Mn | -13.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 386,676.00 |
| Jun 30, 2025 | 386,676.00 |
| Dec 31, 2024 | 346,844.00 |
API Access
Apimeds Pharmaceuticals US Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=APUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "APUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=APUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();